GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Xizang Weixinkang Pharmaceutical Co Ltd (SHSE:603676) » Definitions » Revenue

Xizang Weixinkang Pharmaceutical Co (SHSE:603676) Revenue : ¥1,256 Mil (TTM As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Xizang Weixinkang Pharmaceutical Co Revenue?

Xizang Weixinkang Pharmaceutical Co's revenue for the three months ended in Sep. 2024 was ¥361 Mil. Its revenue for the trailing twelve months (TTM) ended in Sep. 2024 was ¥1,256 Mil. Xizang Weixinkang Pharmaceutical Co's Revenue per Share for the three months ended in Sep. 2024 was ¥0.82. Its Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 was ¥2.90.

Warning Sign:

Xizang Weixinkang Pharmaceutical Co Ltd revenue per share is in decline over the past 12 months.

During the past 12 months, the average Revenue per Share Growth Rate of Xizang Weixinkang Pharmaceutical Co was -10.40% per year. During the past 3 years, the average Revenue per Share Growth Rate was 21.70% per year. During the past 5 years, the average Revenue per Share Growth Rate was 15.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 11 years, Xizang Weixinkang Pharmaceutical Co's highest 3-Year average Revenue per Share Growth Rate was 23.30% per year. The lowest was -10.60% per year. And the median was 15.10% per year.


Xizang Weixinkang Pharmaceutical Co Revenue Historical Data

The historical data trend for Xizang Weixinkang Pharmaceutical Co's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xizang Weixinkang Pharmaceutical Co Revenue Chart

Xizang Weixinkang Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 740.96 715.67 1,033.62 1,398.54 1,322.65

Xizang Weixinkang Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 311.77 261.47 317.84 315.39 361.13

Competitive Comparison of Xizang Weixinkang Pharmaceutical Co's Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Xizang Weixinkang Pharmaceutical Co's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Xizang Weixinkang Pharmaceutical Co's Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Xizang Weixinkang Pharmaceutical Co's Revenue distribution charts can be found below:

* The bar in red indicates where Xizang Weixinkang Pharmaceutical Co's Revenue falls into.


;
;

Xizang Weixinkang Pharmaceutical Co Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1,256 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Xizang Weixinkang Pharmaceutical Co  (SHSE:603676) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Xizang Weixinkang Pharmaceutical Co Revenue Related Terms

Thank you for viewing the detailed overview of Xizang Weixinkang Pharmaceutical Co's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Xizang Weixinkang Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
Yuanqu South Road, 3rd Floor, Building 4, Industrial Center, No. 5, Zone B, Lhasa Economic and Technological, Development Zone, Tibet Autonomous Region, Lhasa, CHN, 850000
Xizang Weixinkang Pharmaceutical Co Ltd is engaged in research & development, production and sales of chemical pharmaceutical preparations and their raw materials. It also produces and sells liver protection drugs and antibiotic products.
Executives
Weng Zi Zhong senior management
Chen Shi Gong Directors, senior managers
Zhou Xiao Bing senior management
Liu Feng Directors, senior managers
Yu Hai Bo senior management
Zhang Hong Directors, senior managers
Zheng Yan Xia senior management
Wen Xiao Quan Director

Xizang Weixinkang Pharmaceutical Co Headlines

No Headlines